Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
2.020
+0.130 (6.88%)
At close: Nov 28, 2025, 1:00 PM EST
2.100
+0.080 (3.96%)
After-hours: Nov 28, 2025, 4:44 PM EST
Immutep Market Cap
Immutep has a market cap or net worth of $293.96 million as of November 28, 2025. Its market cap has increased by 2.21% in one year.
Market Cap
293.96M
Enterprise Value
210.10M
1-Year Change
2.21%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since April 19, 2012, Immutep's market cap has increased from $74.60M to $293.96M, an increase of 294.05%. That is a compound annual growth rate of 10.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 296.50M | -5.93% |
| Dec 31, 2024 | 315.20M | 10.60% |
| Dec 29, 2023 | 285.00M | 87.99% |
| Dec 30, 2022 | 151.60M | -38.22% |
| Dec 31, 2021 | 245.40M | 60.29% |
| Dec 31, 2020 | 153.10M | 152.22% |
| Dec 31, 2019 | 60.70M | 8.98% |
| Dec 31, 2018 | 55.70M | 70.34% |
| Dec 29, 2017 | 32.70M | 125.52% |
| Dec 30, 2016 | 14.50M | -27.50% |
| Dec 31, 2015 | 20.00M | 143.90% |
| Dec 31, 2014 | 8.20M | -29.91% |
| Dec 31, 2013 | 11.70M | -68.03% |
| Dec 31, 2012 | 36.60M | -50.94% |
| Apr 19, 2012 | 74.60M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |